Herbs (Global Traditional) · Ayurveda
Costus (Saussurea costus) (Saussurea costus)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Costus (Saussurea costus) contains bioactive compounds including costunolide and dehydrocostuslactone that demonstrate anti-inflammatory properties. Animal studies show it reduces inflammatory cytokines TNF-α, IL-1β, IL-8, and IL-18 in colitis models.
Saussurea costus (Costus) is a perennial herbaceous plant native to high-altitude regions of the Himalayas in India, Pakistan, and China, belonging to the Asteraceae family. The medicinal preparations primarily use dried roots, from which extracts are obtained using ethanol, acetone, or hexane solvents.
No human clinical trials, RCTs, or meta-analyses were identified for Saussurea costus. Evidence is limited to preclinical animal studies, including a DSS-induced ulcerative colitis mouse model showing anti-inflammatory effects (PMID: 39936162), and in vitro cancer cell line studies demonstrating apoptotic mechanisms.
No clinically studied dosage ranges for humans have been established. Animal studies used unspecified doses of root extracts without standardization details or human dose equivalents. Consult a healthcare provider before starting any new supplement.
Costus root (Saussurea costus) is primarily valued for its bioactive phytochemicals rather than conventional macronutrient content. Key bioactive compounds include: Sesquiterpene lactones: costunolide (major active constituent, ~0.3–1.2% of dry root weight) and dehydrocostus lactone (~0.2–0.8% dry weight), which are the principal anti-inflammatory and anticancer agents. Essential oils: 1–3% total volatile oil content, composed primarily of costol (~5–10% of oil fraction), α-costic acid, β-costic acid, and cyperene. Alkaloids: saussurine (trace amounts, <0.1% dry weight). Sterols: β-sitosterol and stigmasterol present in root lipid fraction. Lignans: lappaol and related compounds detected in minor quantities. Inulin-type fructans: reported as a carbohydrate storage component (~15–20% dry weight), contributing to prebiotic-like properties relevant to gut microbiota modulation. Crude fiber: estimated 10–15% dry weight based on related Asteraceae roots. Protein content is modest, approximately 5–8% dry weight with limited characterization of amino acid profile. Mineral content includes iron, zinc, and calcium at levels typical of dried medicinal roots (iron ~12–18 mg/100g dry weight reported in related analyses). Bioavailability notes: Costunolide and dehydrocostus lactone demonstrate moderate oral bioavailability; sesquiterpene lactones are lipophilic and absorption is enhanced with fat-containing meals. Significant first-pass hepatic metabolism is documented for costunolide. The intact root matrix likely slows release compared to isolated extracts. Standardized extracts are typically normalized to costunolide content. Note: Comprehensive nutritional profiling data (precise vitamin content, complete amino acid profile) remains limited in published literature; most analytical data derives from phytochemical isolation studies rather than full proximate analysis.
Costus root contains sesquiterpene lactones including costunolide and dehydrocostuslactone that inhibit pro-inflammatory cytokine production. These compounds reduce TNF-α, IL-1β, IL-8, and IL-18 levels through modulation of inflammatory pathways. The root also influences gut microbiome composition, potentially through prebiotic effects on beneficial bacteria.
Current evidence for costus is limited to preclinical animal studies, primarily in mouse models of ulcerative colitis. One study (PMID: 39936162) demonstrated significant reductions in inflammatory markers including TNF-α, IL-1β, IL-8, and IL-18 levels. Mouse studies also show alterations in gut microbiome composition, but sample sizes and study durations remain limited. No human clinical trials have been conducted to validate these preliminary findings.
Safety data for costus supplementation is limited due to lack of human clinical trials. Traditional use suggests general tolerability, but potential side effects, optimal dosing, and long-term safety remain undetermined. No specific drug interactions have been documented, though theoretical interactions with anti-inflammatory medications may exist. Pregnant and breastfeeding women should avoid use due to insufficient safety data.
